Safety and Efficacy of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder)When an Optimal Dose is Taken With Varied Carbohydrate Intake

Clinical trial NCT00747006 · TERMINATED

Trial details

NCT number

NCT00747006

Sponsor

Mannkind Corporation

Status

TERMINATED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2008-09-01

Primary completion

2011-02-01

Enrollment

18

View on ClinicalTrials.gov